VLDL Triglyceride Kinetics in Lean, Overweight, and Obese Men and Women
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
CONTEXT: High-plasma very low-density lipoprotein (VLDL) triglyceride (TG) concentration and alterations in VLDL-TG metabolism are associated with cardiometabolic disease. OBJECTIVE: This study sought to evaluate the interrelationships among factors purported to regulate VLDL-TG metabolism in a large cohort of men and women with a wide range in body adiposity and fat distribution but without diabetes. SUBJECTS AND DESIGN: We assessed body composition and fat distribution, plasma insulin concentration, free fatty acid availability, and basal VLDL-TG and VLDL-apoB-100 (VLDL particle number) kinetics in 233 lean, overweight, and obese men and women. RESULTS: We found that: 1) plasma VLDL-TG concentration is determined primarily by VLDL-TG secretion rate (SR) in men and by VLDL-TG clearance rate in women; 2) there is a dissociation between VLDL-TG and VLDL-apoB-100 SRs, and VLDL-apoB-100 SR only explains ∼30% of the variance in VLDL-TG SR; 3) ∼50% of people with obesity have high plasma VLDL-TG concentration due to both an increased VLDL-TG SR and a decreased rate of VLDL-TG plasma clearance, and they have lower plasma high-density lipoprotein-cholesterol concentration and more intra-abdominal and liver fat than those with normal VLDL-TG concentration; and 4) fat-free mass, liver fat content and the rate of free fatty acid release into plasma are independent predictors (with a sex × race interaction) of VLDL-TG SR. CONCLUSIONS: The regulation of plasma VLDL-TG concentration is complex and influenced by multiple metabolic factors. Many people with obesity have normal plasma VLDL-TG concentrations and kinetics, whereas those with high plasma VLDL-TG concentrations have increased VLDL-TG SR and other markers of cardiometabolic disease risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For VLDL, the chronic effects of excess nutrients and insulin resistance are most important, increasing hepatic secretion of larger particles.53,54”
From Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society (2021) · cites this paper as [54]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621
Hokanson, J. E., & Austin, M. A. (1996) · Journal of Cardiovascular Risk · doi:10.1097/00043798-199604000-00014 · Cited by 1,706
AGA technical review on nonalcoholic fatty liver disease
Sanyal, A. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.36572 · Cited by 1,072
Use of metabolic markers to identify overweight individuals who are insulin resistant
McLaughlin, T., Abbasi, F., Cheal, K., Chu, J., Lamendola, C., & Reaven, G. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-10-200311180-00007 · Cited by 1,022
Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity
Fabbrini, E., Magkos, F., Mohammed, B. S., Pietka, T., Abumrad, N. A., Patterson, B. W., Okunade, A., & Klein, S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904944106 · Cited by 972
Self-citationSplanchnic lipolysis in human obesity
Nielsen, S., Guo, Z., Johnson, C. M., Hensrud, D. D., & Jensen, M. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21047 · Cited by 933
Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies
(2010) · The Lancet · doi:10.1016/s0140-6736(10)60545-4 · Cited by 716
Overproduction of large VLDL particles is driven by increased liver fat content in man
Adiels, M., Taskinen, M.-R., Packard, C., Caslake, M. J., Soro-Paavonen, A., Westerbacka, J., Vehkavaara, S., Häkkinen, A., Olofsson, S.-O., Yki-Järvinen, H., et al. (2006) · Diabetologia · doi:10.1007/s00125-005-0125-z · Cited by 690
Fabbrini, E., Mohammed, B. S., Magkos, F., Korenblat, K. M., Patterson, B. W., & Klein, S. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.11.038 · Cited by 631
Self-citationLewis, G. F., Uffelman, K. D., Szeto, L. W., Weller, B., & Steiner, G. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117633 · Cited by 502
Cited by
Ginsberg, H. N., Packard, C. J., Chapman, M. J., Borén, J., Aguilar-Salinas, C. A., Averna, M., Ference, B. A., Gaudet, D., Hegele, R. A., Kersten, S., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab551 · Cited by 979
“53,54 VLDL assembly and secretion are upregulated by (i) the delivery of FA released from insulin-resistant adipocytes, (ii) the increased delivery of remnant TG–FA to the liver due to reduced peripheral lipolysis of chylomicron and VLDL–TG, and (iii) the increased de novo lipogenesis 55 ( Figure 4…”
BackgroundDysregulated lipid metabolism links NAFLD to cardiovascular disease
Deprince, A., Haas, J. T., & Staels, B. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101092 · Cited by 554
Azzu, V., Vacca, M., Virtue, S., Allison, M., & Vidal-Puig, A. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.12.054 · Cited by 369
Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target
Behbodikhah, J., Ahmed, S., Elyasi, A., Kasselman, L. J., De Leon, J., Glass, A. D., & Reiss, A. B. (2021) · Metabolites · doi:10.3390/metabo11100690 · Cited by 270
Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease
Mato, J. M., Alonso, C., Noureddin, M., & Lu, S. C. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i24.3009 · Cited by 199
Intra-pancreatic fat deposition: bringing hidden fat to the fore
Petrov, M. S., & Taylor, R. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00551-0 · Cited by 195
Pathophysiology of Non Alcoholic Fatty Liver Disease
Petta, S., Gastaldelli, A., Rebelos, E., Bugianesi, E., Messa, P., Miele, L., Svegliati-Baroni, G., Valenti, L., & Bonino, F. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17122082 · Cited by 170
Brunt, E. M., Kleiner, D. E., Wilson, L. A., Sanyal, A. J., Neuschwander‐Tetri, B. A., & for the Nonalcoholic Steatohepatitis Clinical Research Network (2019) · Hepatology · doi:10.1002/hep.30418 · Cited by 154
Non-alcoholic Fatty Liver Disease: A Clinical Update
Pappachan, J. M., Babu, S., Krishnan, B., & Ravindran, N. C. (2017) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2017.00013 · Cited by 154
Lipid Metabolism in Metabolic-Associated Steatotic Liver Disease (MASLD)
Syed‐Abdul, M. M. (2023) · Metabolites · doi:10.3390/metabo14010012 · Cited by 180
Why Do Men Accumulate Abdominal Visceral Fat?
Nauli, A. M., & Matin, S. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01486 · Cited by 132
Byrne, C. D., & Targher, G. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14484 · Cited by 140
Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitis
Ghetti, F. D. F., de Oliveira, D. G., de Oliveira, J. M., Ferreira, L. E. V. V. D. C., Cesar, D. E., & Moreira, A. P. B. (2017) · European Journal of Nutrition · doi:10.1007/s00394-017-1524-x · Cited by 130
Emerging Evidence of Pathological Roles of Very-Low-Density Lipoprotein (VLDL)
Huang, J.-K., & Lee, H.-C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084300 · Cited by 102
Bojsen-Møller, K. N., Lundsgaard, A., Madsbad, S., Kiens, B., & Holst, J. J. (2018) · Diabetes · doi:10.2337/db18-0539 · Cited by 102
Postprandial lipemia: factoring in lipemic response for ranking foods for their healthiness
Dias, C. B., Moughan, P. J., Wood, L. G., Singh, H., & Garg, M. L. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0568-5 · Cited by 95
Generoso, G., Janovsky, C. C. P. S., & Bittencourt, M. S. (2019) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000468 · Cited by 69
Pancreatic and mucosal enzymes in choline phospholipid digestion
Nilsson, Å., & Duan, R. (2018) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00320.2018 · Cited by 74
Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profiles
Martínez‐Arranz, I., Bruzzone, C., Noureddin, M., Gil‐Redondo, R., Mincholé, I., Bizkarguenaga, M., Arretxe, E., Iruarrizaga‐Lejarreta, M., Fernández‐Ramos, D., Lopitz‐Otsoa, F., et al. (2022) · Hepatology · doi:10.1002/hep.32427 · Cited by 65
Self-citationSex-based differences in hepatic and skeletal muscle triglyceride storage and metabolism
Beaudry, K. M., & Devries, M. C. (2019) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2018-0635 · Cited by 65
Dysregulation of hepatic metabolism with obesity: factors influencing glucose and lipid metabolism
Nagarajan, S. R., Cross, E., Sanna, F., & Hodson, L. (2021) · Proceedings of The Nutrition Society · doi:10.1017/s0029665121003761 · Cited by 71
Raeeszadeh, M., Beheshtipour, J., Jamali, R., & Akbari, A. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/2691577 · Cited by 66
Diabetes as a risk factor for MASH progression
Gancheva, S., Roden, M., & Castéra, L. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111846 · Cited by 65
Richardson, T. G., Mykkänen, J., Pahkala, K., Ala‐Korpela, M., Bell, J. A., Taylor, K., Viikari, J. S. A., Lehtimäki, T. J., Raitakari, O. T., & Smith, G. D. (2021) · International Journal of Epidemiology · doi:10.1093/ije/dyab051 · Cited by 54
Dietary Energy Partition: The Central Role of Glucose
Remesar, X., & Alemany, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207729 · Cited by 50
Lawitz, E., Li, K. W., Nyangau, E., Field, T., Chuang, J.-C., Billin, A. N., Wang, L., Wang, Y., Huss, R. S., Chung, C., et al. (2022) · Journal of Lipid Research · doi:10.1016/j.jlr.2022.100250 · Cited by 42
Sex-Specific Differences in Lipoprotein Production and Clearance
Conlon, D., Welty, F. K., Reyes‐Soffer, G., & Amengual, J. (2023) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.122.318247 · Cited by 39
Obesity-Related Insulin Resistance: The Central Role of Adipose Tissue Dysfunction
Mocciaro, G., & Gastaldelli, A. (2022) · Handbook of experimental pharmacology · doi:10.1007/164_2021_573 · Cited by 48
Hepatic Fatty Acid Balance and Hepatic Fat Content in Humans With Severe Obesity
Lytle, K. A., Bush, N. C., Triay, J. M., Kellogg, T. A., Kendrick, M. L., Swain, J. M., Gathaiya, N. W., Hames, K. C., & Jensen, M. D. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00875 · Cited by 35
Wang, D., Yin, J., Zhou, Z., Yan, T., Jia, Y., Jie, H., Zhao, J., Li, R., Li, Y., Guo, C. H., et al. (2021) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202100315 · Cited by 32
Fappi, A., & Mittendorfer, B. (2019) · Proceedings of The Nutrition Society · doi:10.1017/s0029665119001022 · Cited by 30
Self-citationPiché, M., Vasan, S. K., Hodson, L., & Karpe, F. (2018) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000522 · Cited by 33
Mucinski, J. M., Manrique‐Acevedo, C., Kasumov, T., Garrett, T. J., Gaballah, A., & Parks, E. J. (2020) · Lipids · doi:10.1002/lipd.12244 · Cited by 27
Shen, N., Li, X., Zheng, S., Zhang, L., Fu, Y., Liu, X., Li, M., Li, J., Guo, S., & Zhang, H. (2019) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2019.04.007 · Cited by 32
HFpEF and MASLD: converging mechanisms and clinical implications
Capone, F., Häseli, S. P., Liu, L., Strocchi, S., Langenberg, C., Lusis, A. J., Pietzner, M., Muoio, D. M., Rider, O. J., Raman, B., et al. (2026) · Nature Reviews Cardiology · doi:10.1038/s41569-026-01257-z · Cited by 37
The Pathogenic Role of Very Low Density Lipoprotein on Atrial Remodeling in the Metabolic Syndrome
Lee, H., & Lin, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030891 · Cited by 26
Deprince, A., Hennuyer, N., Kooijman, S., Pronk, A. C. M., Baugé, E., Liénard, V., Verrijken, A., Dirinck, E. L., Vonghia, L., Woitrain, E., et al. (2022) · Hepatology · doi:10.1002/hep.32631 · Cited by 30
Clot or Not? Reviewing the Reciprocal Regulation Between Lipids and Blood Clotting
Zhang, Z., Rodriguez, M., & Zheng, Z. (2024) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.123.318286 · Cited by 31
Subcutaneous Adipose Tissue Metabolic Function and Insulin Sensitivity in People With Obesity
Koh, H. E., van Vliet, S., Pietka, T., Meyer, G. A., Razani, B., Laforest, R. A., Gropler, R. J., & Mittendorfer, B. (2021) · Diabetes · doi:10.2337/db21-0160 · Cited by 25
Self-citationSerum concentration of fatty acids in children with obesity and nonalcoholic fatty liver disease
Kopiczko, N., Bobrus‐Chociej, A., Harasim‐Symbor, E., Tarasów, E., Wojtkowska, M., Chabowski, A., & Lebensztejn, D. M. (2021) · Nutrition · doi:10.1016/j.nut.2021.111541 · Cited by 23
Amini‐Salehi, E., Hassanipour, S., Joukar, F., Daryagasht, A. A., Khosousi, M., Aleali, M. S., Ansar, M. M., Heidarzad, F., Abdzadeh, E., Vakilpour, A., et al. (2023) · Hepatitis Monthly · doi:10.5812/hepatmon-131523 · Cited by 23
A network analysis of depressive symptoms and metabolomics
Rydin, A. O., Milaneschi, Y., Quax, R., Li, J., Bosch, J. A., Schoevers, R. A., Giltay, E. J., Penninx, B. W. J. H., & Lamers, F. (2023) · Psychological Medicine · doi:10.1017/s0033291723001009 · Cited by 23
Unexplained reciprocal regulation of diabetes and lipoproteins
Higuchi, S., Izquierdo, M. C., & Haeusler, R. A. (2018) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000521 · Cited by 20
Richardson, T. G., Mykkänen, J., Pahkala, K., Ala‐Korpela, M., Bell, J. A., Taylor, K., Viikari, J. S. A., Lehtimäki, T. J., Raitakari, O. T., & Smith, G. D. (2020) · medRxiv · doi:10.1101/2020.08.25.20181412 · Cited by 19
Fernández‐Ramos, D., Lopitz‐Otsoa, F., Millet, Ó., Alonso, C., Lu, S. C.-L., & Mato, J. M. (2022) · Livers · doi:10.3390/livers2040020 · Cited by 24
Tracers and Imaging of Fatty Acid and Energy Metabolism of Human Adipose Tissues
Carpentier, A. C. (2023) · Physiology · doi:10.1152/physiol.00012.2023 · Cited by 27
Lee, H., Shin, S.-J., Huang, J.-K., Lin, M., Lin, Y.-H., Ke, L., Jiang, H., Tsai, W., Chao, M., & Lin, Y. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01386-5 · Cited by 20
Dreher, S. I., Goj, T., von Toerne, C., Hoene, M., Irmler, M., Ouni, M., Jähnert, M., Beckers, J., de Angelis, M. H., Peter, A., et al. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102185 · Cited by 19
Matsubayashi, Y., Yoshida, A., Suganami, H., OSAWA, T., Furukawa, K., Suzuki, H., Fujihara, K., Tanaka, S., Kaku, K., & Sone, H. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13980 · Cited by 18
Smith, K., Dennis, K. M. J. H., & Hodson, L. (2025) · Experimental Physiology · doi:10.1113/ep092001 · Cited by 22
The significances and clinical implications of cholesterol components in human breast cancer
Wei, Y., Huang, Y., Yang, W., Huang, Q., Chen, Y., Zeng, K., Chen, J., & Chen, J. (2021) · Science Progress · doi:10.1177/00368504211028395 · Cited by 16
The role of adiposity, diet and inflammation on the discordance between LDL-C and apolipoprotein B
Webb, R. J., Mazidi, M., Lip, G. Y. H., Kengne, A. P., Banach, M., & Davies, I. G. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.12.004 · Cited by 14
Chondronikola, M., Yoshino, J., Ramaswamy, R. S., Giardina, J. D., Laforest, R. A., Wahl, R. L., Patterson, B. W., Mittendorfer, B., & Klein, S. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101370 · Cited by 17
Self-citationMartini, T., Gobet, C., Salati, A., Blanc, J., Mookhoek, A., Reinehr, M. D., Knott, G. W., Sordet‐Dessimoz, J., & Naef, F. (2024) · Nature Communications · doi:10.1038/s41467-024-52751-2 · Cited by 15
Espinoza, C., Fuenzalida, B., & Leiva, A. (2021) · Current Vascular Pharmacology · doi:10.2174/1570161119666210423085407 · Cited by 15
Lipid Complications after Hematopoietic Stem Cell Transplantation (HSCT) in Pediatric Patients
Bis, G., Szlasa, W., Sondaj, K., Zendran, I., Mielcarek‐Siedziuk, M., & Barg, E. (2020) · Nutrients · doi:10.3390/nu12092500 · Cited by 15
Rivera, K., Quiñones, V., Amigo, L., Santander, N. G., Salas‐Pérez, F., Xavier, A., Fernández‐Galilea, M., Carrasco-Aviño, G., Cabrera, D., Arrese, M. A., et al. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2021.158909 · Cited by 13
Yildirim, V., ter Horst, K. W., Gilijamse, P. W., van Harskamp, D., Schierbeek, H., Jansen, H., Schimmel, A. W. M., Nieuwdorp, M., Groen, A. K., Serlie, M. J. M., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.166905 · Cited by 10
Luque-Urbano, M. R., Fernández‐Ramos, D., Lopitz‐Otsoa, F., de Juan, V. G., Bizkarguenaga, M., Castro-Espadas, L., Hermoso-Martínez, U., Barbier‐Torres, L., Lu, S. C.-L., Millet, Ó., et al. (2025) · Journal of Lipid Research · doi:10.1016/j.jlr.2025.100794 · Cited by 14
Regulation of Adipose Tissue Metabolism During Fasting
Ruppert, P. M. M., & Kersten, S. (2025) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-120524-013857 · Cited by 14
Varsamis, P., Formosa, M. F., Larsen, R. N., Reddy-Luthmoodoo, M., Jennings, G., Cohen, N. D., Grace, M. S., Hawley, J. A., Devlin, B. L., Owen, N. G., et al. (2018) · Clinical Nutrition · doi:10.1016/j.clnu.2018.08.021 · Cited by 11
Chu, P., Yu, Y., Pan, Y., Dai, Y.-H., Yang, J., Huang, K., & Wu, Y. (2024) · Metabolites · doi:10.3390/metabo14020129 · Cited by 10
Cree‐Green, M., Ravi, S., Carreau, A., Sewell, R. L., Baumgartner, A., Coe, G. V., Bergman, B. C., Scherzinger, A. L., Jensen, T., Pyle, L. L., et al. (2019) · Metabolism Open · doi:10.1016/j.metop.2019.100011 · Cited by 9
Holzhütter, H., & Berndt, N. (2021) · Cells · doi:10.3390/cells10030578 · Cited by 11
Unmasking Hormonal Mechanisms of Hypertension in Obesity
Salle, S. P., Tsai, C., Newman, A. J., Chan, J. M., Milks, J., Adler, G. K., Ferrebus, A., Hanna, I., Mahrokhian, S., Pitt, B., et al. (2026) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2026.101526 · Cited by 15
Characterization of sexual dimorphism in ANGPTL4 levels and function
Deng, M., & Kersten, S. (2024) · Journal of Lipid Research · doi:10.1016/j.jlr.2024.100526 · Cited by 8
Vitamin D immune modulation of the anti-inflammatory effects of HDL-associated proteins
Mousa, H., & Zughaier, S. M. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02639-x · Cited by 9
Modeling the effects of genetic- and diet-induced obesity on melanoma progression in zebrafish
Montal, E. D., Lumaquin, D., Ma, Y., Suresh, S., & White, R. M. (2023) · Disease Models & Mechanisms · doi:10.1242/dmm.049671 · Cited by 12
Insenser, M. R., Moncayo, S., Martínez-García, M. Á., Fernández‐Durán, E., Samino, S., Álvarez‐Blasco, F., Luque‐Ramírez, M., & Escobar-Morreale, H. F. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900928 · Cited by 11
Ojeda, D. F. G., Yalcin, Y., Pita-Juárez, Y. H., Hakim, A., Bhattarai, S., Chen, Z., Asara, J. M., Connelly, M. A., Miller, M. R., Lai, M., et al. (2025) · Hepatology Communications · doi:10.1097/hc9.0000000000000716 · Cited by 16
Leptin acutely increases hepatic triglyceride secretion in patients with lipodystrophy
Beghini, M., Metz, M., Baumgartner, C., Wolf, P. S., Bastian, M., Hackl, M. T., Baumgartner-Parzer, S. M., Marculescu, R., Krebs, M., Harreiter, J., et al. (2025) · Metabolism · doi:10.1016/j.metabol.2025.156261 · Cited by 7
Crepaldi, L. D., Mariano, I. R., Trondoli, A. J. P. C., Moreno, F. N., Piovan, S., Formigoni, M., Salgueiro‐Pagadigorria, C. L., de Godoi, V. A. F., Brito, M. D. N., & Garcia, R. F. (2018) · Journal of Pharmacy and Pharmacology · doi:10.17265/2328-2150/2018.10.001 · Cited by 10
Intra- and inter-individual variation of the human lipidome
Anh, N. H., Beyene, H. B., Mocciaro, G., Hahnefeld, L., Lamichhane, S., Fabritius, M., Avela, H. F., Wang, Y., Dickens, A. M., Gurke, R., et al. (2025) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2025.118368 · Cited by 8
Ghebosu, R. E., Gonçalves, J. P., Fitri, N. I., Iannotta, D., Sharifpour, M. F., Coleborn, E., Loukas, A. C., Souza-Fonseca-Guimarães, F., & Wolfram, J. (2025) · Journal of Extracellular Vesicles · doi:10.1002/jev2.70172 · Cited by 8
Advances in Incretin‐Based Therapies for MAFLD: Mechanisms and Clinical Evidence
Dong, W., Zhang, H., Mu, S., Shi, S., Zhang, J., & Xu, K. (2025) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.70131 · Cited by 7
Misceo, D., Mocciaro, G., D’Amore, S., & Vacca, M. (2024) · Nutrition & Metabolism · doi:10.1186/s12986-024-00871-3 · Cited by 7
Vittal, A., Shapses, M. A., Sharma, B., Sharma, D., Sun, Q., Sampson, M. L., Lee, W., Yakov, G. B., & Rotman, Y. (2020) · Hepatology Communications · doi:10.1002/hep4.1658 · Cited by 5
Lipid Dysregulation in Tangier Disease: A Case Series and Metabolic Characterization
Semmler, G., Baumgartner, C., Metz, M., Gensluckner, S., Habisch, H., Hofer, H., März, W., Offner, F. A., Völkerer, A., Petrenko, O., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf131 · Cited by 5
Honka, M., Rebelos, E., Pekkarinen, L., Tuomola, N., Latva‐Rasku, A., Koukkari, L., Immonen, H., Mari, A., Kalliokoski, K. K., Hannukainen, J. C., et al. (2025) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaf054 · Cited by 4
Momeni, S., Hajizadeh‐Sharafabad, F., & Pashaei, M. R. (2025) · Nutrition Research · doi:10.1016/j.nutres.2025.03.005 · Cited by 5
Ashwagandha withanolides, Withaferin-A, and Withanone for natural interventions in aging and obesity
Yoshitomi, R., Nanda, R., Hirano, K., Kaul, S. C., Dhanjal, J. K., & Wadhwa, R. (2025) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2025.112126 · Cited by 4
Harreiter, J., Just, I., Weber, M., Klepochová, R., Bastian, M., Winhofer, Y., Wolf, P. S., Scherer, T., Leutner, M., Kosi‐Trebotic, L., et al. (2024) · Obesity · doi:10.1002/oby.24153 · Cited by 4
QTc Interval is Associated with Atrial Fibrillation in Individuals with Metabolic Syndrome Phenotype
Lee, M.-C., Wang, Y., Li, Y.-J., Tsai, C., Chen, S.-T., Jhuang, W.-J., Chang, M.-C., Chien, M.-Y., & Lee, H. (2022) · International Journal of General Medicine · doi:10.2147/ijgm.s361705 · Cited by 3
Urrunaga‐Pastor, D., Canseco, L. D. L. F. D. D., Toro-Huamanchumo, C. J., Pérez-Zavala, M., & Benites-Zapata, V. A. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.04.039 · Cited by 3
Lipid Transport Across the Mammary Gland
McManaman, J. L. (2020) · Physiology in health and disease · doi:10.1007/978-3-030-55310-4_7 · Cited by 3
Fotros, D., Hekmatdoost, A., & Yari, Z. (2026) · Scientific Reports · doi:10.1038/s41598-026-35525-2 · Cited by 2
Cardiometabolic and metabolic profiles in irritable bowel syndrome associated with type 2 diabetes
Schmelter, F., Nowak, L., Beier, P., Tetzlaff-Lelleck, V., Kordowski, A., Föh, B., Witt, O., Schröder, T., Günther, U. L., Laumonnier, Y., et al. (2026) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00489.2025 · Cited by 3
Arca, M., Björnson, E., D’Erasmo, L., Costanzo, A. D., Bini, S., Minicocci, I., Tramontano, D., Covino, S., Ciarlo, G., Lombardi, M., et al. (2026) · Journal of Internal Medicine · doi:10.1111/joim.70124 · Cited by 2
Fukushima, K., Omura, K., Goshi, S., Okada, A., Tanaka, M., Tsujimoto, T., Iriyama, K., & Sugioka, N. (2021) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.2111 · Cited by 2
Contribution of de novo lipogenesis to the progression of nonalcoholic fatty liver disease
Abdul, M. M. S. (2020) · MOspace Institutional Repository (University of Missouri) · doi:10.32469/10355/81575 · Cited by 2
Dreher, S. I., Goj, T., von Toerne, C., Hoene, M., Irmler, M., Ouni, M., Jähnert, M., Beckers, J., de Angelis, M. H., Peter, A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.12.627717 · Cited by 2
Marchiori, G. N., Soria, E. A., Pasqualini, M. E., Celi, M. A., & Defagó, M. D. (2023) · Human Nutrition & Metabolism · doi:10.1016/j.hnm.2023.200233 · Cited by 2
Nutritional ketosis as therapeutic regimen for metabolic disorders: Perspectives and challenges
Ul‐Haq, I., Saleem, K., Iftikhar, H., & Abdi, G. (2025) · Journal of Agriculture and Food Research · doi:10.1016/j.jafr.2025.101981 · Cited by 3
Human milk lipids: an overview
McManaman, J. L., Carli, J. F. M., & Monks, J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-815350-5.00004-8 · Cited by 1
Sobotka, L. (2017) · Springer eBooks · doi:10.1007/978-3-319-53171-7_1
Salroo, I. N., Bashir, M., Bhat, R. A., Sayeed, S. I., & Salroo, N. A. (2020) · Journal of Clinical Medicine of Kazakhstan · doi:10.23950/1812-2892-jcmk-00732
ОЦІНКА ВПЛИВУ НАЯВНОСТІ У ПАЦІЄНТІВ НАДЛИШКОВОЇ МАСИ ТІЛА НА ФІБРОЗ ПЕЧІНКИ
Gavryliuk, N., Hospodarskyy, I., Прокопчук, О. В., & Havrylyuk, M. E. (2021) · Здобутки клінічної і експериментальної медицини · doi:10.11603/1811-2471.2020.v.i4.11635
Matshipi, M., Siweya, H. J., & Makgae, P. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.95938
Lee, H., Shin, S., Huang, J.-K., Lin, Y.-H., Ke, L., Jiang, H., Tsai, W., Chao, M., & Lin, Y. (2020) · Research Square · doi:10.21203/rs.3.rs-34109/v1
Updates in the Epidemiology of Fatty Liver and its Consequences in Saudi Arabia: A Review
Alanazi, B. M. (2022) · Journal of Pharmaceutical Research International · doi:10.9734/jpri/2022/v34i46b36387
Metadata
- Authors
- Mittendorfer, B., Yoshino, M., Patterson, B. W., & Klein, S.
- Affiliations
- Washington University in St. Louis (US)
- Corresponding author
- Mittendorfer, Bettina
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2016-11
- Volume
- 101
- Issue
- 11
- Pages
- 4151-4160
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC5095238
- OpenAlex
- W2514898138
- Cited by
- 108
- References
- 45
- Citations by year
- 2026: 11 · 2025: 15 · 2024: 10 · 2023: 7 · 2022: 10 · 2021: 18 · 2020: 16 · 2019: 9 · 2018: 7 · 2017: 4 · 2016: 1
- FWCI
- 5.76
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5p60dk020579-35, 5t32dk007296-35, UL1TR000448)
- National Institute of General Medical Sciences (P41GM103422)
- National Institute of Diabetes and Digestive and Kidney Diseases (T32-DK007296, R01DK037948, R01DK094483, P60-DK-020579, P30DK092950, P30DK056341, P30DK020579, T32DK007120)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR049869)
- National Center for Advancing Translational Sciences
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P50HD057796)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- obesity, adiposity, body fat distribution, liver fat, intra-abdominal fat, fat-free mass, sex differences, cardiometabolic risk, HDL cholesterol, insulin
- MeSH terms
- Adipose Tissue, Adolescent, Adult, Female, Humans, Kinetics, Lipoproteins, VLDL, Male, Middle Aged, Obesity, Triglycerides, Body Mass Index, Overweight, Apolipoprotein B-100, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.